Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atracurium versus cisatracurium in electroconvulsive therapy
IRCT20161001030072N5Phase 3Recruiting
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in mental disorder comparing Atracurium arm with Cisatracurium arm (2 arms). Primary endpoints: Seizure duration, Time to return of effective breathing and 2 more. Started Jul 2026; status: recruiting.
02
Drugs
atracuriumcisatracurium
03
Conditions
mental disorder
Beyond the preview
Go deeper on IRCT20161001030072N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161001030072N5.